盘后数据出炉。 1月21日，A股市场整体上涨。截至收盘，上证指数报4116.94点，上涨0.08%；深证成指报14255.13点，上涨0.7%；创业板指数报3295.52点，上涨0.54%； 北证50指数上涨0.14%。 1.A股市场主力资金净流入56.08亿元 今日A股市场主力资金开盘净流出41.97亿元，尾盘净流入6.26亿元，A股市场全天主力资金净流入56.08亿元。 | | | 沪深两市近五日主力资金流向情况(亿元) | | | | --- | --- | --- | --- | --- | | 日期 | | | 净流入金额 开盘净流入 尾盘净流入 超大单净买入 | | | 2026-1-21 | 56. 08 | -41.97 | 6.26 | 154. 57 | | 2026-1-20 | -764. 07 | -221.93 | -61.61 | -471.97 | | 2026-1-19 | -397.98 | -162.72 | -58. 29 | -209.12 | | 2026-1-16 | -238.85 | -106. 45 | -38. 37 | -133.83 | | 2026- ...

Group 1 - The ChiNext market indices, including the ChiNext Mid 200 Index and the ChiNext Growth Index, have shown positive performance with increases of 0.6% and 0.5% respectively [1] - The Ministry of Industry and Information Technology highlighted the emergence of numerous high-innovation results, with advancements in perovskite materials, permanent magnet materials, and power batteries reaching international advanced levels [1] - New technologies such as quantum technology-based atomic clocks and magnetometers have successfully been developed, alongside breakthroughs in superconducting quantum computers and optical quantum computers achieving quantum superiority [1] Group 2 - The ChiNext Growth ETF tracks the ChiNext Growth Index, which consists of 50 stocks characterized by strong growth, good profit expectations, and high liquidity, with the information technology sector accounting for over 40% of the index [2] - The combined share of the telecommunications, power equipment, electronics, computers, and pharmaceutical biotechnology sectors in the ChiNext Growth Index is nearly 85% [2] - The ChiNext Index was launched on June 1, 2010, while the ChiNext Mid 200 Index was introduced on November 15, 2023 [2]

证券之星消息，1月21日，生物经济（970038）指数报收于2249.37点，涨0.3%，成交272.77亿元，换手 率2.27%。当日该指数成份股中，上涨的有28家，迪安诊断以5.59%的涨幅领涨，下跌的有22家，康弘药 业以1.78%的跌幅领跌。 生物经济（970038）指数十大成份股详情如下： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 000021 | 深科技 | 1.87亿 ﮯ | 3.06% | -9441.13万 | -1.55% | -9272.83万 | -1.52% | | 300142 | 沃森生物 | 6444.78万 | 8.62% | -3115.26万 | -4.16% | -3329.52万 | -4.45% | | 000930 | 中粮科技 | 5427.62万 | 9.84% | 491.65万 | 4 0.89% | -5919.27万 | -10.73% | | 002 ...

Core Viewpoint - The average stock price of A-shares is 14.68 yuan, with 33 stocks priced below 2 yuan, the lowest being *ST Changyao at 0.64 yuan [1] Group 1: Stock Price Distribution - As of January 21, the Shanghai Composite Index closed at 4116.94 points, with an average A-share price of 14.68 yuan [1] - There are 33 stocks priced below 2 yuan, with *ST Changyao having the lowest price at 0.64 yuan, followed by *ST Aowei at 0.81 yuan and *ST Lifang at 0.96 yuan [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 24.24% of the total [1] Group 2: Market Performance of Low-Priced Stocks - Out of the low-priced stocks, 10 saw an increase today, with *ST Changyao rising by 20.75%, *ST Lifang by 20.00%, and *ST Jinke by 1.37% [1] - Conversely, 19 stocks experienced declines, with Dongtong Tui dropping by 6.52%, *ST Aowei by 4.71%, and Yongtai Energy by 1.20% [1] Group 3: Low-Priced Stock Rankings - The table lists various low-priced stocks, including their latest closing prices, daily change percentages, turnover rates, and industry classifications [1][2] - Notable stocks include *ST Changyao (0.64 yuan, +20.75%), *ST Aowei (0.81 yuan, -4.71%), and *ST Lifang (0.96 yuan, +20.00%) [1][2]

Core Viewpoint - The article discusses the potential investment opportunities in various ETFs, particularly focusing on the Hong Kong stock market and sectors such as pharmaceuticals, entertainment, and finance, driven by favorable economic conditions and government policies [3][4][5][8][11]. Group 1: Hong Kong Stock Market ETFs - The Hong Kong Stock Connect 50 ETF (159712.SZ) is expected to see a net buy of 1,404.84 billion HKD from southbound funds in 2025, a 73.89% increase from 2024, indicating strong inflows into the Hong Kong market [3]. - This ETF tracks the CSI Hong Kong Stock Connect 50 Index, covering over 57% of the market capitalization of Hong Kong stocks, balancing traditional and new economy sectors [4]. Group 2: Pharmaceutical Sector ETFs - The Hang Seng Pharmaceutical ETF (159892.SZ) is positioned to benefit from lower financing costs for pharmaceutical companies due to the Federal Reserve's interest rate cuts, enhancing their R&D capabilities [5]. - China holds approximately 30% of the global new drug pipeline, with 76 innovative drugs approved in 2025, indicating a robust domestic pharmaceutical industry [5]. Group 3: Entertainment Sector ETFs - The Film and Television ETF (159855.SZ) is anticipated to gain from the upcoming Spring Festival, which may boost market expectations and lead to a short-term rally in the sector [8]. - Government initiatives, such as the "China Film Consumption Year," aim to stimulate cultural consumption, potentially increasing audience engagement and spending in the film industry [8]. Group 4: Financial Sector ETFs - The Securities and Insurance ETF (512070.SH) is expected to benefit from active market trading, with a record turnover of 3.12 trillion RMB on January 9, 2026, positively impacting brokerage and margin financing businesses [11]. - Recent regulatory changes are likely to enhance capital efficiency for leading brokerages and relax investment restrictions for insurance companies, further supporting growth in the financial sector [11].

Group 1 - A-shares indices collectively rose, with the Shanghai Composite Index increasing by 0.29% [1] - The CSI 1000 ETF saw a rise of 0.89%, while other major indices like the SSE 50 and CSI 300 also experienced gains [1] - Among the top 50 weighted stocks in the CSI 1000 ETF, notable gainers included Zhongtung High-tech (+10.00%), Yuntian Lifeng (+8.55%), and Jucheng Co. (+8.10%) [1] Group 2 - The electronic sector rose by 2.71%, while other sectors such as power equipment and pharmaceuticals also showed positive performance [1] - Recent government policies aim to reduce financing costs and lower barriers for private enterprises, addressing the challenges of high financing costs and difficulties in obtaining financing [2] - Analysts suggest that the A-share market retains strong upward momentum due to factors like increased household savings entering the market and a new wave of technological industrial revolution [2]

Group 1 - The core viewpoint of the report indicates that the overall opportunities in the equity market for 2026 outweigh the risks, with AI remaining the main theme of global technological innovation [1] - As of the end of Q4 2025, the stock position of the Silver Hua Xinyi fund was 88.55%, a decrease of 4.54 percentage points compared to the end of Q3 2025 [1] - The top ten holdings of the fund as of Q4 2025 include Tencent Holdings, Alibaba-W, SMIC, Meituan-W, Xiaomi Group-W, Focus Media, Shenzhou International, Yili Group, Luzhou Laojiao, and Wuliangye [1] Group 2 - The AI industry is experiencing explosive growth in capital expenditure globally, with domestic internet companies also showing rapid growth in capital spending [2] - The consumer sector is expected to lag in 2025, with consumers remaining cautious and price-sensitive, although there are opportunities in high-quality consumer stocks with attractive dividend yields [2] - The pharmaceutical sector experienced fluctuations in Q4, attributed to previously high market expectations and capital flowing to other popular sectors, but there is a long-term positive outlook for domestic innovative drugs and the CRO/CDMO segments [2]

Core Viewpoint - The news discusses various ETFs tracking the STAR Market indices, highlighting their focus on high-growth sectors such as technology and healthcare, and their respective performance metrics since inception. Group 1: ETF Overview - The STAR Market 50 ETF tracks the STAR Market 50 Index, consisting of 50 large-cap stocks with significant liquidity, primarily in the semiconductor sector, which accounts for over 65% of the index [2] - The STAR Market 100 ETF follows the STAR Market 100 Index, focusing on 100 mid-cap stocks, with over 75% of its composition in electronics, power equipment, and biomedicine [2] - The STAR Market 200 ETF tracks the STAR Market 200 Index, which includes 200 small-cap stocks, with nearly 70% in electronics, biomedicine, and machinery sectors [2] Group 2: Performance Metrics - The STAR Market 50 Index has a rolling price-to-earnings (P/E) ratio of 173.4 times and a valuation percentile of 96.9% since its launch in July 2020 [2] - The STAR Market 100 Index has a rolling P/E ratio of 218.1 times, with a valuation percentile of 89.3% since its launch in August 2023 [2] - The STAR Market 200 Index has a rolling P/E ratio of 350.1 times, reflecting its focus on growth potential in smaller companies [2] Group 3: Growth Focus - The STAR Growth ETF tracks the STAR Growth Index, which includes 50 stocks with high growth rates in revenue and net profit, predominantly in the electronics and communications sectors, which together account for over 65% of the index [3] - The STAR Growth Index has a rolling P/E ratio of 232.3 times and a valuation percentile of 89.3% since its launch in November 2022 [3]

Group 1 - The core viewpoint emphasizes that technological innovation, particularly in artificial intelligence and smart manufacturing, is a key driver for market indices, with strategic emerging industries pushing the index upward [1] - The "Artificial Intelligence+" initiative has been included in the 14th Five-Year Plan, indicating accelerated technological breakthroughs and industrial applications [1] - The ChiNext 50 Index, representing new economy sectors, is expected to benefit from multiple drivers including technological innovation, industrial upgrades, and policy dividends [1] Group 2 - The ChiNext 50 ETF (159375) tracks the ChiNext 50 Index (399673), which has a daily price fluctuation limit of 20% and selects 50 securities with high average trading volumes from the ChiNext market [1] - The industry allocation of the index is focused on emerging growth areas such as power equipment and new energy, pharmaceuticals, and information technology, reflecting the performance of companies with strong growth and high technological innovation attributes [1]

Core Viewpoint - 62 companies listed on the Sci-Tech Innovation Board have provided earnings forecasts for 2025, with 21 companies expecting losses, 20 expecting profit increases, 14 expecting reduced losses, 5 expecting profit declines, and 2 expecting profits [1]. Group 1: Earnings Forecasts - Among the 62 companies, 20 are expected to increase profits, and 2 are expected to be profitable, resulting in a total of 35.48% of companies reporting positive forecasts [1]. - The companies with the highest expected profit growth include Baiwei Storage with a median profit increase of 473.71%, followed by Zhongke Lanyun at 371.51% and Baiaosaitu at 303.57% [1][3]. - Industries with significant profit growth include electronics, machinery, and biomedicine, with 7, 4, and 3 companies respectively showing profit increases of over 50% [1]. Group 2: Stock Performance - Sci-Tech Innovation Board stocks with high earnings growth have averaged a 17.21% increase in stock price this year [1]. - Baiwei Storage has seen the largest stock price increase of 65.85%, followed by Qiangyi Co. and Oke Yi with increases of 45.25% and 30.53% respectively [1]. Group 3: Capital Flow - In terms of capital flow, stocks with significant earnings growth have seen net inflows, with Lankai Technology, Dingtong Technology, and Baiwei Storage receiving net inflows of 569 million, 342 million, and 199 million respectively over the past five days [2]. - Conversely, stocks like Qiangyi Co., Zhongke Lanyun, and Baiaosaitu have experienced net outflows of 185 million, 114 million, and 99.92 million respectively [2].